Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
May 30 2024 - 1:47PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the
Securities Exchange Act of 1934
May 30,
2024
Commission
File Number 001-14978
SMITH & NEPHEW plc
(Registrant’s
name)
Building 5, Croxley Park, Hatters Lane
Watford, England, WD18 8YE
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form
20-F ✓
Form 40-F __
SMITH & NEPHEW PLC
30 May 2024
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE
REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY
PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND
PERSONS CLOSELY ASSOCIATED WITH THEM.
On 29 May 2024, Smith & Nephew plc (the "Company") received
notification of the following transactions as detailed
below.
Reason for the notification
|
Initial notification /Amendment
|
Initial notification
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
Name
|
Smith & Nephew plc
|
LEI
|
213800ZTMDN8S67S1H61
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
Description
of the financial instrument, type of instrument
|
Smith
& Nephew plc SPON ADR American Depositary Shares
(ADS)
|
Identification code
|
ISIN: US83175M2052
|
Nature of the transaction
|
Director and PDMRs are participants of the Company's Employee Stock
Purchase Plan, which purchased American Depository Shares through
the Company's Dividend Re-Investment Plan following the 2023 final
dividend payment on 22 May 2024.
|
Date of Transaction
|
2024-05-24
|
Place of Transaction
|
New York Stock Exchange
|
Name
|
Director / PDMR
|
Price ($)
|
Volume
|
Aggregated information
|
Craig Gaffin
(President, Global Orthopaedics)
|
PDMR
|
24.9026
|
24.14366
|
N/A Single Transaction
|
Mizanu Kebede
(Chief Quality & Regulatory Affairs Officer)
|
PDMR
|
24.9026
|
18.50369
|
N/A Single Transaction
|
Deepak Nath
(Chief Executive Officer)
|
Director
|
24.9026
|
24.14366
|
N/A Single Transaction
|
Paul Connolly
(President, Global Operations)
|
PDMR
|
24.9026
|
18.16357
|
N/A Single Transaction
|
Scott Schaffner
(President, Sports Medicine)
|
PDMR
|
24.9026
|
44.13636
|
N/A Single Transaction
|
Sarah Carne
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477100
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
|
|
|
Smith & Nephew plc
|
|
|
(Registrant)
|
|
|
|
|
|
|
Date:
May 30, 2024
|
By:
|
/s/
Helen Barraclough
|
|
|
Helen
Barraclough
|
|
|
Company
Secretary
|
Smith and Nephew (PK) (USOTC:SNNUF)
Historical Stock Chart
From Nov 2024 to Dec 2024
Smith and Nephew (PK) (USOTC:SNNUF)
Historical Stock Chart
From Dec 2023 to Dec 2024